24Feb 2024
Pitavastatin Reduces Noncalcified Coronary Plaque in HIV Patients: Study Reveals Promising Results

Pitavastatin Reduces Noncalcified Coronary Plaque in HIV Patients: Study Reveals Promising Results

A study revealed that pitavastatin significantly reduces noncalcified coronary plaque in people with HIV, potentially mitigating cardiovascular risks. The study showed a 35% decrease in major adverse cardiovascular events (MACE). Pitavastatin lowered noncalcified plaque volume and progression, alongside reducing lipid oxidation and arterial inflammation markers. These findings suggest promising cardiovascular benefits for HIV patients at low to moderate risk.

  • #cardiology

Like

Save

Share